BioHealth Computing
Chrysovalanto Louka
Chrysovalanto Louka

Chrysovalanto Louka’s research focuses on the toxicity of Zinc Oxide (ZnO) Nanowires (NWs) in skin cells, related to their physicochemical characterisation, their life cycle and changes during exposure to the cells. She is a holder of a BSc in Biomedicine from the University of East Anglia, U.K. and an MSc in Nanomedicine from Swansea University, U.K.

 

She is currently in her second year of a joint PhD between Swansea University, U.K and University of Grenoble, France. Through her PhD project, she aims to define exposure limits of ZnO NWs, potential toxicity mechanisms and a method of making them safer for human, ecosystem and environmental use, by coating them. She has been working with different cytotoxicity assays (LDH, MTT, Trypan blue), Zinc dissolution assay, cell culture techniques (HaCaT cells) as well as microscopy and fluorescence (SEM, BSEM light microscopy, dark field, Fluorescence Microscopy Fluo 4, MMP). She has been trained to fabricate ZnO NWs as well as handling and coating them.